Back to Search
ANNE TSAO, M.D.
M.D.
Medical Oncology Physician
NPI: 1932291739IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
L2712(TX)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
UNIVERSITY OF CHICAGO, PRITZKER SCHOOL OF MEDICINE
Class of 1998
Research & Publications (20)
Neoadjuvant and intrapleural therapies for malignant pleural mesothelioma.
PMID 19289370·Clin Lung Cancer·2009
6-review
Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion.
PMID 17620427·Mol Cancer Ther·2007
8-other
Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.
PMID 17409862·J Thorac Oncol·2006
8-other
Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.
PMID 16943532·J Clin Oncol·2006
3-trial
Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.
PMID 16634096·Cancer·2006
4-observational
Phase I evaluation of docetaxel and topotecan for patients with advanced solid tumors.
PMID 15139070·Cancer·2004
3-trial
C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcome.
PMID 15109537·Leuk Res·2004
8-other
Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies.
PMID 12869408·Cancer Epidemiol Biomarkers Prev·2003
8-other
Robot-assisted laparoscopic prostatectomy: the first 100 patients-improving patient safety and outcomes.
PMID 19245295·J Endourol·2009
8-other
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.
PMID 19404214·J Thorac Oncol·2009
3-trial
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
PMID 18349398·J Clin Oncol·2008
3-trial
What patient and surgical factors contribute to implant wear and osteolysis in total joint arthroplasty?
PMID 18612018·J Am Acad Orthop Surg·2008
8-other
Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.
PMID 17453966·Cytotherapy·2007
8-other
Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.
PMID 17954086·Ann Thorac Surg·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1932291739
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile